Intrahepatic Cholangiocarcinoma: Emerging Insights from Pathobiology to Clinical Translation – Innovative Strategies, Challenges, and Opportunities

33
Total downloads
1,804
Total views and downloads

Participate in this topic

Articles

CASE REPORT

Accepted on 20 Jun 2025

EPSTEIN-BARR VIRUS NEGATIVE LYMPHOEPITHELIOMA-LIKE CHOLANGIOCARCINOMA: A RARE TUMOR THAT DESERVES FURTHER EXPLORATION. REPORT OF A CASE WITH DISTINCT GENOMIC AND CLINICAL FEATURES

Salvatore Corallo
Chiara Milani
Alessandro Vanoli
Anna Gallotti
ANNA PAGANI
Francesco Serra
Marcello Maestri
Valentina Ravetta
Angioletta Lasagna
1 more
Francesco Agustoni

doi 10.3389/fonc.2025.1620328

171 views

ORIGINAL RESEARCH

Accepted on 12 Jun 2025

Interventional treatment combined with immunotargeted therapy in unresectable combined hepatocellular-cholangiocarcinoma: a real-world retrospective cohort study Running head: Triple therapy for cHCC-CCA

Yan-Song Lin
Li-Yan Wu
Lihui Lin
Xia Yang
Fang-Yi Liu
Yan-Qin Wu
Zhen Ding
Yu-Jing Liang
Jing-Ping Yun

doi 10.3389/fimmu.2025.1591127

192 views

ORIGINAL RESEARCH

Published on 06 Jun 2025

Who benefits from adjuvant chemotherapy? Identification of early recurrence in intrahepatic cholangiocarcinoma patients after curative-intent resection using machine learning algorithms

Qi Li
Hengchao Liu
Yubo Ma
Zhenqi Tang
Chen Chen
Dong Zhang
Zhimin Geng

doi 10.3389/fonc.2025.1594200

789 views

Share on

Frontiers in Oncology

Frontiers in Oncology

Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

1,804Topic views
1,150Article views
33Article downloads